Abstract
Inhibition of virus-induced intracellular signaling pathways and viral infectivity are our ultimate goals in the development of effective antiviral agents to control human cytomegalovirus (HCMV) infections. The HCMV hyperimmune globulin may meet such criteria. In a human embryonic lung (HEL) fibroblast culture model, pretreatment of Towne strain HCMV with HCMV hyperimmune globulin was shown to inhibit viral infectivity successfully, as measured by a standard plaque assay. The extracellular viral titers and extracellular viral DNA, as measured by plaque assay and PCR, respectively, were also decreased. In addition, the HCMV hyperimmune globulin prevented HCMV from inducing the intracellular activation of NF-kappaB, Sp-1, and PI3-K signaling pathways. The PI3-K pathway was examined by following phosphorylation (activation) of two of its downstream kinases, Akt and p70S6K. HCMV hyperimmune globulin also prevented the production of immediate early, early, and late viral proteins. These studies show that HCMV hyperimmune globulin neutralization of HCMV prevents the earliest known events observed after viral envelope glycoproteins bind their cell membrane receptors, i.e., NF-kappaB, Sp-1 and PI3-K activation. This suggests that HCMV ...Continue Reading
References
Oct 1, 1992·Molecular and Cellular Biology·M WadeJ C Azizkhan
Oct 22, 1987·The New England Journal of Medicine·D R SnydmanA S Levey
Oct 1, 1983·Antimicrobial Agents and Chemotherapy·E C MarE S Huang
Jul 1, 1994·Virology·T F KowalikE S Huang
Nov 15, 1993·Annals of Internal Medicine·D R SnydmanUNKNOWN Boston Center for Liver Transplantation CMVIG Study Group
May 1, 1996·Trends in Biochemical Sciences·C G Proud
Dec 16, 1996·FEBS Letters·D R AlessiP Cohen
May 12, 1997·Virology·W A BresnahanT Albrecht
Jun 12, 1997·Nature·A Toker, L C Cantley
Jun 23, 1997·FEBS Letters·N Pullen, G Thomas
Aug 1, 1997·The Journal of General Virology·W A BresnahanT Albrecht
Aug 5, 1998·Oncogene·A BellacosaP Tsichlis
Oct 6, 1998·Annual Review of Biochemistry·D A FrumanL C Cantley
May 13, 1999·Antiviral Research·R A JohnsonE S Huang
Dec 2, 1999·Experimental Cell Research·B Vanhaesebroeck, M D Waterfield
Jan 11, 2000·Journal of Virology·R A JohnsonE S Huang
Mar 4, 2000·The Biochemical Journal·B Vanhaesebroeck, D R Alessi
Jul 6, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C SengenèsJ Galitzky
Feb 15, 2001·The Journal of General Virology·R A JohnsonE S Huang
Jun 8, 2001·Journal of Virology·R A JohnsonE S Huang
Citations
Feb 3, 2012·Medical Microbiology and Immunology·K FrenzelJ Hofmann
Feb 16, 2010·Journal of Thrombosis and Thrombolysis·Milan PopovićYves Laumonnier
Dec 14, 2011·Journal of Thrombosis and Thrombolysis·Milan PopovićEsma R Isenović
Sep 13, 2008·Journal of Virology·Rebecca L SandersDeborah H Spector
Jan 1, 2013·American Journal of Physiology. Lung Cellular and Molecular Physiology·Andreas SchwingshacklChristopher M Waters
Mar 24, 2015·Virology·XueQiao Liu, Jeffrey I Cohen
Aug 11, 2004·Antiviral Research·David L EversEng-Shang Huang
Jan 18, 2005·Antiviral Research·David L EversEng-Shang Huang
Oct 17, 2006·Oncogene·M N Corradetti, K-L Guan
Aug 15, 2008·Nature·Liliana SoroceanuCharles S Cobbs
Apr 14, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N G RouphaelG M Lyon
Jul 24, 2010·The American Journal of Pathology·Ekaterina MaidjiLenore Pereira
May 25, 2021·Frontiers in Microbiology·Byeong-Jae LeeAndrew D Yurochko
Mar 9, 2007·Journal of Immunological Methods·Anna Maria AbaiMary K Wloch
Jan 22, 2005·Journal of Medicinal Chemistry·Hosup YeoYung-Chi Cheng